Related Experiment Video
Updated: Aug 9, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
Published on: September 28, 2016
Structure-Function Studies of Sponge-Derived Compounds on the Cardiac CaV3.1 Channel
Anne-Sophie Depuydt1, Piyush A Patel2, Žan Toplak3
1Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium.
Marine sponge alkaloids, purpurealidin analogs, were identified as novel inhibitors of T-type calcium (CaV3) channels. These compounds show potential for treating heart conditions by blocking ion flow in CaV3.1 channels.
Area of Science:
- Cardiovascular Pharmacology
- Ion Channel Modulation
- Marine Natural Products Chemistry
Background:
- T-type calcium (CaV3) channels are crucial for cardiac function, with their role amplified in heart failure.
- Current therapeutic options for modulating CaV3 channels are limited, highlighting the need for novel inhibitors.
Purpose of the Study:
- To discover and characterize novel inhibitors of T-type calcium channels using purpurealidin analogs.
- To investigate the structure-activity relationships of purpurealidin analogs for CaV3.1 channel inhibition.
- To elucidate the mechanism of action of potent purpurealidin analogs.
Main Methods:
- Electrophysiological investigation of rat CaV3.1 channels using 119 purpurealidin analogs.
- Structure-activity relationship (SAR) studies to identify key structural features for inhibition.
- Mechanism of action studies, including activation curve analysis and selectivity screening against hERG channels.
Main Results:
- Purpurealidin I and 119 analogs were evaluated; analogs 74, 76, 79, and 99 demonstrated potent CaV3.1 inhibition (IC50 ≈ 3 μM).
- No shift in activation curves indicated a pore-blocking mechanism, obstructing ion flow through the CaV3.1 channel.
- Selectivity screening revealed activity on hERG channels, suggesting potential off-target effects.
Conclusions:
- A novel class of T-type calcium channel inhibitors, derived from purpurealidin alkaloids, has been identified.
- SAR studies provide valuable insights for the rational design of synthetic CaV3 channel modulators.
- Further research is needed to optimize selectivity and assess in vivo efficacy and safety.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Mechanically-gated Ion Channels
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...

